finance.yahoo.com (nprofile…pkyy)
https://s.yimg.com/ny/api/res/1.2/s96w_II11VB7SkipZ4PriQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/6c091d4d20fc00f664b4c025dd5573f5
https://finance.yahoo.com/news/day-one-biopharmaceuticals-inc-dawn-144705847.html
finance.yahoo.com / Yahoo! Finance
npub1va…rwc3n
2025-05-14 22:40:31
Author Public Key
npub1vap2usgr7nawhqexfk247ap0nfs34jqpjrxqqslrkv3rrrx8aessgrwc3nPublished at
2025-05-14 22:40:31Event JSON
{
"id": "4ad7429eac1d478c717637b169a47b9d88a42b28c44dc9ae6266db0efb2c2a31",
"pubkey": "6742ae4103f4faeb83264d955f742f9a611ac80190cc0043e3b322318cc7ee61",
"created_at": 1747262431,
"kind": 1,
"tags": [
[
"r",
"https://finance.yahoo.com/news/day-one-biopharmaceuticals-inc-dawn-144705847.html"
],
[
"subject",
"Is Day One Biopharmaceuticals, Inc. (DAWN) the Best Low Priced Biotech Stock to Buy Now?"
],
[
"published_at",
"1747147625"
],
[
"image",
"https://s.yimg.com/ny/api/res/1.2/s96w_II11VB7SkipZ4PriQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/6c091d4d20fc00f664b4c025dd5573f5"
],
[
"p",
"6742ae4103f4faeb83264d955f742f9a611ac80190cc0043e3b322318cc7ee61",
"wss://relay-testnet.k8s.layer3.news"
],
[
"imeta",
"url https://s.yimg.com/ny/api/res/1.2/s96w_II11VB7SkipZ4PriQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/6c091d4d20fc00f664b4c025dd5573f5"
],
[
"t",
"finance:perspective"
],
[
"summary",
"The article begins by discussing the recent publication of a list of the 10 best low-priced biotech stocks to buy now. It then focuses on Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) and its potential as an investment opportunity. The article quotes Michael Yee, a senior biotech analyst at Jefferies, who notes that the biotech industry is facing several challenges, including tariffs and policy risks. Despite these challenges, Yee believes that low valuations in the sector may present buying opportunities once the uncertainty clears. The article also highlights the company's pipeline and its potential for long-term growth."
]
],
"content": "nostr:nprofile1qy3hwumn8ghj7un9d3shjtt5v4ehgmn9wshxkwrn9ekxz7t9wgejumn9waesqgr8g2hyzql5lt4cxfjdj40hgtu6vydvsqvsesqy8canygcce3lwvyyapkyy\nhttps://s.yimg.com/ny/api/res/1.2/s96w_II11VB7SkipZ4PriQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/6c091d4d20fc00f664b4c025dd5573f5\n\nhttps://finance.yahoo.com/news/day-one-biopharmaceuticals-inc-dawn-144705847.html",
"sig": "3a43755186c01f1cba6c1e6d02d3814807c3879f53031423edf5a3535c10b5a4dfacb4829e47e3f7844ee4dc604dc50f2d56b5b1a25f13d94a31244c5e579685"
}